Slingshot members are tracking this event:
Viiv Healthcare Presents Results from 2 Phase 3 Studies Evaluating Dolutegravir + Rilpivirine in HIV Maintenance
Slingshot Insights Explained
Dec 20, 2016
Don’t see a project related to the catalyst you care about?
Related Keywords Phase 3, Dolutegravir, Rilpivirine